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ABSTRACT A number of cytokines sharing limited se-
quence homology have been grouped as a family because of
partially overlapping biological activities, receptor subunit
promiscuity, and the prediction of a shared secondary struc-
ture. Since several of these cytokines regulate gene expression
and cell number in the nervous and hematopoietic systems, this
specific group is termed the neuropoietic cytokine family. Using
a reverse transcription-polymerase chain reaction-based assay
system for monitoring the expression of multiple phenotypic
markers in cultured sympathetic neurons, we present further
evidence that, in addition to cholinergic differentiation factor/
leukemia inhibitory factor and ciliary neurotrophic factor,
oncostatin M, growth promoting activity, interleukin 6, and
interleukin 11 belong in this family. In addition, one member
of the transforming growth factor .8 superfamily, activin A,
shares a selective overlap with the neuropoietic family in the
spectrum of neuropeptides that it induces in sympathetic
neurons. The particular neuropeptides induced by activin A,
however, demonstrate that the activity of this cytokine is
distinct from that of the neuropoietic family. Twenty-six other
cytokines and growth factors were without detectable activity
in this assay.
Diffusible proteins can regulate neural development at a
number of stages, from the initial proliferation and differen-
tiation of progenitor cells, through the outgrowth of pro-
cesses and formation of synapses, to the rearrangement of
connections in postnatal life (1). Two of the families of
proteins involved in these events include the neurotrophins
and the neuropoietic cytokines. The prototype of the former
group is nerve growth factor (NGF), and subsequent family
members were cloned by utilizing the extensive homology
between NGF and the second neurotrophin identified, brain-
derived neurotrophic factor. In contrast, the neuropoietic
family is emerging not through strong homologies among
cytokine sequences, but rather by shared biological activities
and predicted secondary structures (2, 3). Subsequent studies
on the receptors for the neuropoietic cytokines have revealed
not only structural homology among the receptors but the
sharing ofa common receptor transducing subunit and similar
signal-transducing pathways (4-8).
Inaugural members of the neuropoietic family include a
protein we termed the cholinergic differentiation factor
(CDF; refs. 9-11), also widely known as leukemia inhibitory
factor (LIF; ref. 12), and ciliary neurotrophic factor (CNTF;
refs. 13-15). These two proteins display identical profiles of
activity in the regulation of neuropeptide expression in cul-
tured sympathetic neurons (16, 17) and in the support of
motor neuron survival (18, 19). In addition, Bazan (2) pre-
dicted that CDF/LIF and CNTF would share a similar
secondary structure with interleukin (IL)-6, oncostatin M
(OSM), and granulocyte colony-stimulating factor (G-CSF).
Similar predictions were made by Rose and Bruce (20). While
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it was known that CDF/LIF and IL-6 elicited many of the
same responses in nonneural cells (21), the linkage with OSM
was not previously suspected. Further evidence for a close
relationship between these proteins is the finding that OSM
can displace CDF/LIF from its binding sites on Ml cells (22).
Moreover, OSM was recently found to induce the same
neuropeptide in a neuroblastoma line as CDF/LIF (23).
Another candidate for membership in this family is IL-11, a
cytokine that phosphorylates the same gpl3O receptor sub-
unit as do CDF/LIF, CNTF, and IL-6 (5, 24). Recently,
growth-promoting activity (GPA), a protein that shares
trophic activity for ciliary neurons with CNTF, was cloned
from chicken and found to have a limited sequence homology
with mammalian CNTF (25). Finally, extracts of rat foot pads
(which contain sweat glands, the target of cholinergic sym-
pathetic neurons) were found to contain a protein, termed the
sweat gland factor (SGF), that exhibits both CDF/LIF and
CNTF activities and is similar to, but distinct from, CNTF
(26, 27). SGF has not as yet been sequenced. All of these
proteins are therefore candidates for membership in the
neuropoietic cytokine family.
Other cytokines may be involved in the development ofthe
nervous system. IL-3 acts as a trophic factor for central
cholinergic neurons (28), and IL-5, -7, -9, and -11 regulate
differentiation of murine hippocampal progenitor cells (29).
IL-1 and tumor necrosis factor a (TNFa), two inflammatory
cytokines released after injury, can induce NGF and CDF/
LIF, which in turn have effects on neuronal survival and gene
expression (30-32). Activin A, a member of the transforming
growth factor P (TGF8) superfamily, stimulates expression
of the neuropeptide somatostatin in cultured ciliary ganglion
neurons (33). Accordingly, these cytokines are candidate
neuronal differentiation factors. Nonetheless, there has been
no systematic analysis of the effects of these cytokines on
neuronal phenotype.
We have designed a reverse transcription (RT)-PCR assay
to analyze the effects of soluble factors on the expression of
neuropeptides and neurotransmitter synthesizing enzymes in
cultured sympathetic neurons. In this assay, CDF/LIF and
CNTF induce an identical set of neuropeptide and neuro-
transmitter enzyme mRNAs (34). We here present the results
of testing the effects of 33 different recombinant cytokines
and growth factors on neuronal gene expression. These
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results support the hypothesis that GPA and OSM belong in
the neuropoietic family. In addition, weak activities of IL-6
and IL-11 can also be detected in this assay. The pattern of
neuronal gene expression induced by activin A, however,
sets it apart from this family.
MATERIALS AND METHODS
Animals and Reagents. Neonatal Sprague-Dawley rats
were purchased from Simonsen Laboratories (Gilroy, CA).
Most of the tissue culture reagents, Superscript reverse
transcriptase II, and the 1-kb DNA marker were purchased
from GIBCO/BRL. NGF, glycogen, dATP, dCTP, dGTP,
dTTP, acidic fibroblast growth factor (FGF) and basic FGF
were purchased from Boehringer Mannheim. RNase inhibi-
tor (RNasin) and Taq DNA polymerase were purchased from
Promega. Oligo(dT) was obtained from Pharmacia. Oligonu-
cleotide primers were synthesized in the Biopolymer Syn-
thesis and Analysis Resource Center at Caltech. The recom-
binant proteins murine IL-1, murine TNF-a, human activin
A, human growth-related cytokine a (GROa), and rat CNTF
were gifts from Genentech. Chick GPA was kindly provided
by T. Finn and Rae Nishi of Oregon Health Sciences Uni-
versity (Portland). Human recombinant activin A was also
obtained from Jim Smith at the National Institute for Medical
Research (London). Human macrophage inflammatory pro-
tein la (MIPla) was provided by Mary Freshney and Gerry
Graham at the Beatson Institute for Cancer Research (Glas-
gow, U.K.). The recombinant proteins murine IL-3, -4, -6, -7,
and -9, human IL-8, and macrophage colony stimulating
factor (M-CSF) were purchased from R & D Systems. The
recombinant protein human IL-10 was supplied from Gen-
zyme. The recombinant protein human IL-il was a gift from
Yu-Chung Yang at Indiana University. The recombinant
protein murine IL-12 was provided by Stanley Wolf from
Genetics Institute (Cambridge, MA). The recombinant pro-
tein human OSM was provided by David Gearing at Im-
munex. Other cytokines and growth factors used in this study
were recombinant human (rh) proteins provided by James
Miller and colleagues at Amgen. All other reagents were
purchased from Sigma.
Neuronal Culture. Dissociated sympathetic neurons were
prepared and cultured in serum-free medium as described
previously (34-36). For reproducibility, neurons were seeded
in 96-well plates (Falcon), at a density of one ganglion per
well. Cultures were maintained for 7 days, and half of the
medium was changed every 36 hr in an effort to ensure that
cytokines maintained activity. The antimitotic agent aphidi-
colin was added to the cultures at the concentration of 4
pug/ml, effectively eliminating nonneuronal cells. After 7
days, each well contained approximately 3000 neurons, and
more than 95% of the surviving cells were neurons, asjudged
by phase-contrast microscopy (36). Cytokines and growth
factors were added from the second day of culture, and
duplicate wells were prepared for each condition. All results
reported here were reproduced in at least two separate
neuronal platings.
Preparation ofRNA and cDNA. Total RNA preparation and
cDNA synthesis from cultured neurons were as described
previously (34). Briefly, 160 Al of lysis buffer was added to
each well. The lysate was transferred to a 1.7-ml Eppendorf
tube and swirled vigorously to shear DNA, and then one
round of acidic phenol/chloroform extraction was performed
to deplete DNA and proteins. RNA was coprecipitated with
30 Mg of glycogen in a 50% isopropyl alcohol solution and
stored at -20°C overnight.
To produce cDNA from the cultured neurons, the total
RNA was centrifuged, dried, and directly dissolved in 10 ,ul
of 13 mM methylmercury hydroxide for 10 min, and an
additional 2 ,ul of 75 mM 2-mercaptoethanol was added for 5
min. Oligo(dT)-primed RT was done in a final volume of 20
,ul, containing the RT buffer (34), 100 units of reverse
transcriptase, and 20 units of RNasin, for 1 hr at 37°C.
PCR. The sequences of the primers and conditions used in
the PCR for each neuronal gene analyzed were described in
a previous report (34). Amplification ofcDNA was performed
in a thermal cycler (MJ Research, Watertown, MA). Each
tube contained a final volume of 20 /.l, consisting of 1 ,ul of
cDNA, lx PCR buffer (Promega), 0.5 unit of Taq DNA
polymerase, 0.25mM dNTP, and one set ofprimers (200 nM).
After the reaction, 8 Al of each PCR sample was analyzed on
a 2% agarose gel, and the products were visualized after
ethidium bromide staining and UV illumination. The appro-
priate amplification cycle schedule for each neuropeptide
gene was determined empirically, to allow a minimal, yet
detectable, signal for control samples (neurons grown with-
out cytokines or growth factors). Cytokines were deemed to
have regulatory effects on specific genes if the intensities of
the PCR products were about 3-fold different from those of
negative controls, as judged by eye.
RESULTS
Screening of33 Cytokines and Growth Factors for Effects on
Neuronal Gene Expression. In the first screen for effects of
cytokines and growth factors on neuronal phenotype, two
concentrations (10 ng/ml and 100 ng/ml) ofeach recombinant
protein were applied to neonatal rat sympathetic neurons in
culture for 6 days. The expression pattern of different neu-
romodulators in the presence ofcytokines and growth factors
was elucidated by the RT-PCR assay and the results are
summarized in Table 1. Twenty-six factors showed no effect
on the intensity of the PCR products for any of the six genes
analyzed, in at least two independent experiments; these
factors were not analyzed further. In addition to reporting our
findings with CDF/LIF and CNTF, we report here in detail
for the first time the effects of GPA, OSM, IL-6, IL-11, and
activin A on neuronal gene expression. Some of the inductive
effects of CDF/LIF, CNTF, and OSM have been demon-
strated previously (16, 17, 23, 34, 37).
GPA Induces the Same Set of Neuropeptides and Neuro-
transmitter Synthetic Enzymes as CNTF. GPA was purified
from chick and has the same ciliary neurotrophic activity as
mammalian CNTF. Moreover, the amino acid sequence of
GPA shows a 50% identity to the sequences for human, rat,
and rabbit CNTF (25). In contrast to CNTF, however, GPA
has been shown to be secreted from cells in a transient
transfection experiment (25). We tested whether GPA has the
same effects as CNTF on cultured sympathetic neurons, and
the results are illustrated in Fig. 1. The ,B-actin band was used
to monitor the amount ofmRNA present in each sample, and
duplicate samples were prepared for each condition. GPA
induces mRNAs for the neuropeptides substance P (SP),
enkephalin (ENK), vasoactive intestinal polypeptide (VIP),
cholecystokinin (CCK), and somatostatin (SOM), as well as
the enzyme for synthesizing acetylcholine, choline acetyl-
transferase (ChAT), in a dose-dependent manner. This pat-
tern ofneuropeptide induction is very similar to that ofCNTF
and CDF/LIF. We also analyzed expression of the mRNAs
for the enzymes synthesizing yaminobutyric acid (glutamic
acid decarboxylase; GAD65 and GAD67 for the 65- and
67-kDa forms), the enzyme for synthesizing catecholamines
(tyrosine hydroxylase; TH), the enzyme for synthesizing
serotonin (tryptophan hydroxylase; TPH), and the neuropep-
tides calcitonin gene-related peptide (CGRP), dynorphin
(DYN), and neuropeptide Y (NPY). As with CNTF, GPA has
no detectable inductive effect on these genes at the mRNA
level (data not shown). This identity in the expression pat-
terns of 13 neuropeptide and neurotransmitter mRNAs
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Table 1. Regulation of gene expression in sympathetic neurons
CGRP, GAD,
Cytokines CCK ChAT ENK SOM SP VIP DYN, NPY TH, TPH
Neuropoietic
CDF/LIF, CNTF, GPA ++ + ++ ++ +++ + - -
OSM + + + + + + + - -
IL-6, IL-11 - - - - + - - -
G-CSF - - - - - - - - -
Other
Activin A + + - ++ - - + +
IL-la, -2, -3, -4, -5, -7, -8, -9, -10, -12,
IFN-'y, GM-CSF, M-CSF, EPO,
TGFa, TGF3, EGF, IGF-1, TNFa,
SCF, MIPla, GROa, PDGF, acidic
FGF, basic FGF - - - - - - ND ND
A + indicates that there is induction effect; a - indicates that there is no induction effect; ND, not determined. Cytokines not previously
defined: IFN- y, interferon y; EPO, erythropoietin; TGFa and
-,B, transforming growth factor a and (3; EGF, epidermal growth factor; IGF-1,
insulin-like growth factor 1; SCF, stem cell factor; PDGF, platelet-derived growth factor. Neuropeptides and enzymes in column heads are
defined in the text.
strengthens the idea that GPA and CNTF share many bio-
logical activities.
OSM, IL-6, and IL-1l Have Activity in the Symptthetic
Neuron Assay. OSM and CDF/LIF have the same biological
activities in several assay systems, including triggering dif-
ferentiation of Ml leukemia cells and the induction of the
acute phase response in hepatocytes (38, 39). Recently,
Gearing and colleague (22) provided evidence that OSM
binds to the CDF/LIF receptor with high affinity. To test the
effects of OSM on sympathetic neurons, various concentra-
tions of human OSM were applied and the expression of
neuroiial genes was analyzed. For comparison, CDF/LIF at
1.6 ng/ml was included in sister cultures. The data in Fig. 2
illustrate that OSM induces mRNAs for SP, ENK, ChAT,
and CCK, but only at concentrations (>25 ng/ml) higher than
required for similar inductive effects by CDF/LIF. OSM
induces a low level of mRNA for SOM, even at 400 ng/ml.
It is possible that this quantitative difference is due to the
species difference between OSM (human) and the target
neurons (rat). Reduced responsiveness of rat cells to OSM
was also demonstrated in an acute phase protein assay (39).
Like GPA, OSM does not induce the expression of the
mRNAs for GAD65, GAD67, TH, TPH, CGRP, DYN, and
NPY (data not shown).
As outlined in the introduction, there are results raising the
possibility that several other cytokines may belong to the
neuropoietic family. These include G-CSF, IL-6, and IL-11.
These proteins were tested in the sympathetic neuron assay,
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FIG. 1. Rat CNTF and chicken GPA induce mRNAs for SP,
ENK, VIP, ChAT, CCK, and SOM with a similar dose dependency.
Various concentrations (ng/ml) of rat CNTF and chicken GPA were
added to cultured sympathetic neurons from day 2 to day 7. Duplicate
samples were run for each concentration. The relative abundance of
each mRNA was analyzed by RT-PCR. The expression of ,B-actin
was used to monitor the amount ofRNA in each sample. The DNA
molecular weight standard (m lane) is a 1-kb DNA marker.
along with CDF/LIF for comparison, and the results are
illustrated in Fig. 3. G-CSF has no detectable activity on the
expression of any of the genes analyzed. IL-6 and IL-11, in
contrast, induce preprotachykinin mRNA (which produces
the SP neuropeptide). This effect is weak and is observed
only at concentrations of >100 ng/ml. Among the several
genes influenced by CDF/LIF and CNTF, SP is the one that
displays the most striking response (>100-fold increase; ref.
16). Therefore, rather than displaying more specificity than
CDF/LIF and CNTF, it could be that IL-6 and IL-11 are such
weak inducers that only an increase in SP can be observed.
Activin A Induces a Different Set ofNeuronal Genes. Activin
A is a member of the TGFf3 superfamily and has effects on
erythroid differentiation, embryonic mesoderm induction
and axis formation, and sexual development (40). Although
this protein does not belong jn the neuropoietic cytokine
family on the basis of structure, it does have effects on
neuronal gene expression. Since it was recently demon-
strated that activin A can induce SOM in ciliary ganglion
neurons (33), it was of interest to determine whether activin
A has similar effects on sympathetic neurons. In fact, activin
A elicits an induction pattern of mRNAs for neuropeptides
and neurotransmitter synthetic enzymes that is distinct from
that of CNTF and CDF/LIF. As illustrated in Fig. 4, CDF/
LIF induces mRNAs for SP, ENK, and VIP but does not alter
the expression of CGRP and DYN mRNAs. Activin A, in
contrast, does not alter the expression of SP, ENK, and VIP
mRNAs, even at the concentration of 400 ng/ml, but it does
have potent effects on CGRP and DYN mRNAs (Fig. 4).
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FIG. 2. OSM induces mRNAs for SP, ENK, ChAT, CCK, and
SOM, but only at high concentrations. Various concentrations
(ng/ml) of rhOSM, or rhCDF/LIF at 1.6 ng/ml, were added to
cultured sympathetic neurons from day 2 to day 7 and RT-PCR was
used to monitor mRNA expression of neuropeptides and transmitter
biosynthetic enzymes. Duplicate samples were prepared for each
condition. Induction ofmRNAs for SP and ENK occurs at 25 ng/ml.
At 100 ng/ml, rhOSM begins to induce mRNAs for ChAT and CCK.
Induction of SOM was just visible at 400 ng/ml.
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FIG. 3. High concentrations of IL-6 and IL-li induce expression
of mRNA for SP, while G-CSF has no effect on the neuronal genes
tested. Various concentrations (ng/ml) of rhIL-l1, rhG-CSF, recom-
binant murine IL-6, or rhCDF/LIF at 1.6 ng/ml were added to
neuronal cultures and the effects were analyzed by RT-PCR. Dupli-
cate samples were prepared for each condition. IL-6 and IL-li begin
to show induction of SP at 100 ng/ml, but they do not induce other
neuromodulators.
Moreover, while CDF/LIF down-regulates the expression of
mRNA for TH and NPY, activin A induces higher levels of
NPY mRNA, while TH mRNA levels appear to be unaltered.
Activin A and CDF/LIF do have some similarities in action;
both induce ChAT, SOM, and CCK mRNAs, and both have
no effect on GAD67, GAD65, and TPH mRNAs.
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FIG. 4. Recombinant human activin A induces a novel set of
neuronal genes; this induction is not blocked by recombinant human
inhibin A and is additive to the effects of CDF/LIF. rhCDF/LIF at
1.6 ng/ml or activin A at various concentrations (ng/ml) was applied
to neurons and the effects were analyzed by RT-PCR. For the
blocking experiment, activin A at 25 ng/ml and inhibin A at 200 ng/ml
were added to the cultures and the results are shown in lane b. The
effects of activin A alone at 25 ng/ml are shown in lane a, and inhibin
A alone at 200 ng/ml in lane c. To observe additive effects, CDF/LIF
at 1.6 ng/ml and activin A at 25 ng/ml were added together (lane d).
Duplicate samples were prepared for each condition. Although
inhibin A inhibits NPY induction by activin A in this set of samples,
this result was not observed consistently, and no other inhibitory
effects were seen.
Two proteins, inhibin and follistatin, inhibit the action of
activin A. We tested one of them, inhibin A, at the concen-
tration (200 ng/ml) that was shown previously to inhibit
induction of erythroid differentiation by activin A at 25 ng/ml
(33). In the sympathetic neuron assay inhibin has no effect by
itself on the neuronal genes tested (Fig. 4, lane c), nor does
it block the effects of activin A when these two proteins are
added together (Fig. 4, lane b). This lack of effect suggests
that these neurons have the type of activin A receptor that
does not recognize inhibin A. When activin A and CDF/LIF
are added together in the assay, each at a concentration
sufficient to generate maximal inductive effects in this assay,
additive effects are observed (Fig. 4, lane d). This implies that
activin A and CDF/LIF use different mechanisms to regulate
neuronal gene expression.
DISCUSSION
The utility of an RT-PCR-based assay for screening factors
that may affect neuronal gene expression is borne out by the
present results. Thirty-three cytokines and growth factors
were tested for their effects on the expression of a variety of
neuropeptides and transmitter-synthesizing enzymes that are
known to be present in the peripheral nervous system. Active
factors can be quickly identified, and dose-response exper-
iments allow a qualitative assessment of which genes respond
to each factor. As illustrated by the results presented here,
assays of a smaller subset of neuronal genes could have led
to conclusions entirely different from those we derive from
the larger data set. Although this method is qualitative,
comparison of dose-response results obtained with known
cytokines allows an accurate analysis of the effects of novel
factors.
As summarized in Table 1, most of the factors tested did
not alter the expression of phenotypic markers in cultured
sympathetic neurons. We cannot rule out, however, the
possibility that some of these cytokines might have been
active had we been able to screen the recombinant rat
proteins. Further studies using neurons and cytokines de-
rived from the same species are necessary to clarify this
uncertainty. Indeed, Mehler and colleagues (29) have pro-
vided evidence that IL-5, -7, -9, and -11 are survival and/or
differentiation factors for murine hippocampal progenitor
neurons. Another example is FGF. Both acidic FGF and
basic FGF induce the cholinergic phenotype in cultured chick
sympathetic neurons (41), but we were not able to observe
any change of expression in rat sympathetic neurons in
several trials. Other differences in responsiveness to factors
have been observed between rat and chicken sympathetic
neurons (e.g., ref. 42).
CNTF was identified and cloned from human, rat, and
rabbit by its ability to support the survival of ciliary neurons
in vitro, and later it was also found to maintain the survival
of motor neurons. It does not contain a signal peptide for
secretion, however, and it is not detected in the medium of
transfected cells (14, 15). Moreover, CNTF is not found in
tissue fluids or extracellular matrix preparations, except after
axonal injury (43). A protein with CNTF-like activity (SGF)
is found in the soluble fraction of sweat gland homogenates,
raising the possibility that there exists a secretable CNTF
homologue (26, 27). This idea is supported by the finding that
the chick expresses a secretable protein that displays 50%
amino acid sequence identity with CNTF (25). Our laboratory
has recently cloned a partial cDNA for a different CNTF
sequence homologue from chicken, however, and this mol-
ecule appears to be the chicken version of mammalian CNTF
(44). Therefore, chicken GPA is also likely to be a family
member. The present finding that GPA possesses an activity
on sympathetic neurons identical to that of CNTF and
CDF/LIF further solidifies the position ofGPA in this family.
Proc. Natl. Acad Sci. USA 91 (1994)
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The present results also provide further support for OSM
as a neuropoietic cytokine. Although OSM shows only a
modest sequence homology with CDF/LIF, it can displace
the latter from its receptor on Ml cells, and if this is also the
case for the sympathetic neurons, the mechanism for how
these two cytokines can regulate the same set of neuronal
genes is straightforward. We provide evidence that IL-6 and
IL-1l weakly induce expression of SP, and not the other
genes tested. Since it appears that IL-6, IL-li, CNTF,
CDF/LIF, and OSM use the same receptor subunit as a
signal transducer, gpl3O, the relatively weak effects observed
here for IL-6 and IL-li may indicate very low levels of the
ligand-binding subunits for the latter two cytokines in sym-
pathetic neurons.
The observation that activin A induces a distinctive subset
of neuronal genes is important for two reasons. First, it
demonstrates that the various neuropeptide genes assayed
can, in fact, be regulated independently of each other. That
is, the observations that CCK, ENK, SP, VIP, and ChAT are
all induced together by CDF/LIF, CNTF, GPA, and OSM is
not simply due to a mandatory coordinate regulation of these
neuropeptide genes. The activin A results thus serve to
further link the neuropoietic group together. The lack of
induction of SP by activin A is particularly striking, given the
extraordinarily strong induction of this neuropeptide by all of
the neuropoietic cytokines. The second point of interest in
the activin A findings is that the particular set of neuropep-
tides induced by this factor closely resembles the neuropep-
tide phenotype of the cholinergic sympathetic neurons that
innervate the sweat gland in the rat foot pad. The presence of
CGRP induction and the absence of SP induction are impor-
tant because cholinergic sympathetic neurons express
CGRP, but not SP, in rats (45). On this basis, activin A is a
legitimate candidate, along with SGF, for the target-derived
neuronal differentiation factor that induces sympathetic neu-
rons innervating sweat glands to become cholinergic. It will
therefore be of interest to determine if activin A is expressed
in the sweat glands during normal development.
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